dexamethasone intravitreal Ozurdex
Selected indexed studies
- Dexamethasone intravitreal implant (OZURDEX(®)) for macular edema secondary to noninfectious uveitis: a review of the literature. (Ther Deliv, 2019) [PMID:31184554]
- OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion. (Retina, 2019) [PMID:31206423]
- Reverse engineering the Ozurdex dexamethasone intravitreal implant. (Int J Pharm, 2023) [PMID:36690129]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dexamethasone intravitreal implant (OZURDEX(®)) for macular edema secondary to noninfectious uveitis: a review of the literature. (2019) pubmed
- OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion. (2019) pubmed
- Reverse engineering the Ozurdex dexamethasone intravitreal implant. (2023) pubmed
- A review of ten years of experience using dexamethasone intravitreal implants (Ozurdex) for uveitis. (2023) pubmed
- Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. (2014) pubmed
- CASE REPORT OF ABIOTROPHIA DEFECTIVA ENDOPHTHALMITIS AFTER REPEATED INJECTIONS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX). (2022) pubmed
- OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT. (2017) pubmed
- Efficacy of Intravitreal Dexamethasone Implant (Ozurdex(®)) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. (2025) pubmed
- INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO STEREOTACTIC RADIOTHERAPY FOR POSTERIOR UVEAL MELANOMA. (2019) pubmed
- Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment. (2016) pubmed